Device for tissue section immobilization and retention

US2025067638A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2025067638-A1
Application numberUS-202418943398-A
CountryUS
Kind codeA1
Filing dateNov 11, 2024
Priority dateOct 25, 2021
Publication dateFeb 27, 2025
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed herein, inter alia, are devices and methods for transfer and analysis of tissue sections using carrier substrates.

First claim

Opening claim text (preview).

What is claimed is: 1 . A device comprising: a solid support comprising a plurality of discrete tissue samples attached to the solid support, wherein each discrete tissue sample comprises: a tissue section comprising a width of about 4 mm to about 10 mm and a thickness of about 5 μm to about 12 μm; and a hydrogel substrate attached to the tissue section. 2 . The device of claim 1 , wherein each tissue section is a formalin-fixed and paraffin embedded (FFPE) tissue section. 3 . The device of claim 1 , wherein each tissue section is a frozen tissue section. 4 . The device of claim 1 , wherein a length, width, and/or diameter of each tissue section is about 4 mm to about 10 mm. 5 . The device of claim 1 , wherein a thickness of each tissue section is about 1 μm to about 20 μm. 6 . The device of claim 1 , wherein a thickness of each tissue section is less than 6 μm, 7 μm, 8 μm, 9 μm or 10 μm. 7 . The device of claim 1 , wherein each tissue section comprises breast tissue, lung tissue, colon tissue, lymph tissue, kidney tissue, bone tissue, tonsil tissue, or brain tissue. 8 . The device of claim 1 , wherein each tissue section bonds to the hydrogel substrate via a first bond having a first adhesion strength, and wherein the tissue section bonds to the solid support via a second bond having a second adhesion strength, wherein the second adhesion strength is greater than the first adhesion strength. 9 . The device of claim 1 , wherein the hydrogel substrate comprises agarose, amylose, or amylopectin. 10 . The device of claim 1 , wherein the hydrogel substrate comprises 2% to 5% agarose. 11 . The device of claim 1 wherein the hydrogel substrate comprises 3% to 20% acrylamide. 12 . The device of claim 1 , wherein the solid support is glass. 13 . A method of detecting nucleic acids in a tissue section, comprising: contacting the device of claim 1 with a plurality of circularizable probes, wherein a circularizable probe binds to a nucleic acid molecule in the tissue section; forming a circular oligonucleotide in the tissue section, and amplifying the circular oligonucleotide to form amplification products; and detecting the amplification products by binding a fluorescently labeled probe to the amplification product and detecting the fluorescent label. 14 . The method of claim 13 , wherein prior to contacting the device with a plurality of circularizable probes, the hydrogel substrate is removed. 15 . The method of claim 13 , wherein the nucleic acid molecule is attached to a specific binding agent. 16 . The method of claim 13 , wherein the nucleic acid molecule is an RNA molecule. 17 . The method of claim 13 , wherein the nucleic acid molecule is a cDNA molecule. 18 . The method of claim 13 , where the tissue section comprises is liver tissue, kidney tissue, lung tissue, thymus tissue, adrenal tissue, skin tissue, bladder tissue, colon tissue, spleen tissue, or brain tissue. 19 . The method of claim 13 , wherein the fluorescently labeled probe is a fluorescently labeled nucleotide. 20 . The method of claim 13 , wherein the fluorescently labeled probe is a fluorescently labeled oligonucleotide.

Assignees

Inventors

Classifications

  • Reducing the nucleic acid content · CPC title

  • with fluorescent label · CPC title

  • Nucleic acid amplification reactions · CPC title

  • Enzymatic or biochemical coupling of nucleic acids to a solid phase · CPC title

  • Nucleic acid detection involving sensors · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2025067638A1 cover?
Disclosed herein, inter alia, are devices and methods for transfer and analysis of tissue sections using carrier substrates.
Who is the assignee on this patent?
Singular Genomics Systems Inc
What technology area does this patent fall under?
Primary CPC classification G01N1/30. Mapped technology areas include Physics.
When was this patent published?
Publication date Thu Feb 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).